Refine by
Patient Diagnostic Articles & Analysis
236 news found
Advanced equipment, such as specialized gynecology tables and rotary vane medical vacuum pumps, enhances precision and patient comfort in surgical settings. In diagnostics, the use of antigen rapid test kits and in vitro diagnostic hematology is accelerating early disease detection, improving treatment outcomes. ...
In July 2021, the company received $153,300 for a $204,400 project to develop a prototype drape to shield medical imaging machines from patient contamination. “As a company founded and headquartered in Ontario, we are committed to helping to improve the health of Ontarians through our on-going development of innovative technology,” said Cameron Piron, President, ...
It is particularly useful in enabling the very young, frail, or patients with a disability to perform respiratory assessments, as no forced maneuver is required. Speaking of the new addition to the Vitalograph family of respiratory diagnostic solutions, Vice President of Global Marketing for Vitalograph, Ross Warner said: “The addition of oscillometry is ...
Vitalograph, a global leader in the development and production of respiratory diagnostic solutions and clinical trial services, has launched the Vitalograph tremoflo® C-100 at this year’s ATS International Conference, taking place in Washington. ...
Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces five new hospitals have implemented the Company’s BVA-100 blood volume diagnostic for clinical use to guide fluid management in heart failure patients during the first quarter of 2023. ...
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 diagnostic in optimizing individualized therapy for heart failure patients. ...
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new pilot randomized control trial (RCT) data from Duke Heart validating the greater accuracy of the Company’s BVA-100 diagnostic in optimizing decongestion therapy for heart failure patients and pointed to a strong signal toward reducing hospital length ...
Oak Ridge, TN – March 23, 2023 — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company’s BVA-100 diagnostic in optimizing individualized therapy for heart failure patients. ...
Oak Ridge, TN – March 23, 2023 — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new pilot randomized control trial (RCT) data from Duke Heart validating the greater accuracy of the Company’s BVA-100 diagnostic in optimizing decongestion therapy for heart failure patients and pointed to ...
Instand-NGS4P is a Horizon 2020 funded project that shares BC Platforms vision for improving cancer patients’ diagnostics. This is achieved by developing and providing integrated and standardized workflows for Next Generation Sequencing (NGS) and integrating information from cancer gene testing, pharmacogenetics testing and e-medication, to support medical ...
Next, extended ambulatory ECG monitoring from our products, compared to shorter monitoring, more accurately estimates the burden of a common type of ventricular arrhythmia, which is clinically consequential to patients and important to get right. We also found that atrial fibrillation was an unexpected and important finding in patients who receive monitoring for ...
” Krestin also expects that FRI will provide added value for patients. Patients already get diagnostic computerized tomography (CT) scans when recommended. ...
ByFluidda
Regulatory clearance makes Entegrion’s innovative point of care diagnostic instrument for viscoelastic coagulation testing available to clinicians in Europe. ...
Through APCaRI, the Lewis team established a patient data registry and biorepository that has grown into one of the largest prostate cancer databases in the world. ...
This research opens a new interesting way to look at the very rare cancer cells in the patient bloodstream. Rarecells Diagnostics (France), a leading liquid biopsy company, is pleased to announce that the University Medical Center of Groningen, The Netherlands, has published research comparing the performance of the ISET technology to the reference ...
Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical Care Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical ...
The total cost to rapidly identify organisms from positive blood cultures could be at least fifty percent less than what you're paying today for a rapid molecular ID solution," said Jack Phillips, President, and CEO of Accelerate Diagnostics. "When you think of the extreme pressure that labs are under today, the Arc is a fast and inexpensive diagnostic tool which ...
Proprietary microRNA signature (miRisk) may support immunotherapy treatment decisions as a blood-based complementary diagnostic Results published in Journal of Thoracic Oncology Clinical and Research Reports Hummingbird Diagnostics GmbH, a leader in reading blood-based microRNAs for early disease detection and characterization, today announced a publication ...
She brings decades of global experience in clinical research and development, commercialization, patient engagement, and regulatory strategy. Prior to joining Altoida, Dr. ...
MOUNTAIN VIEW, Calif., May 26, 2022 – G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced that two posters were presented at Digestive Disease Week Conference held in San Diego in from May 21 through May 24. ...